NeuBase Therapeutics Stock Forecast - Period Momentum Indicator

NBSEDelisted Stock  USD 1.62  0.17  9.50%   
NeuBase Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast NeuBase Therapeutics stock prices and determine the direction of NeuBase Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of NeuBase Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
  
NeuBase Therapeutics has current Period Momentum Indicator of (0.17). Momentum indicator evaluates the difference between todays closing price and the close price n periods ago. It is the velocity with which the price is rising or falling. It also reflects how aggressively the asset is purchased or sold by the public.
Check NeuBase Therapeutics VolatilityBacktest NeuBase TherapeuticsInformation Ratio  

NeuBase Therapeutics Trading Date Momentum

On November 30 2024 NeuBase Therapeutics was traded for  1.62  at the closing time. The top price for the day was 1.83  and the lowest listed price was  1.60 . There was no trading activity during the period 0.0. Lack of trading volume on November 30, 2024 did not cause price change. The trading delta at closing time against the current closing price is 10.49% .
Generally speaking extended values of the momentum indicator over time are good indicators of oversold or over brought conditions.
Compare NeuBase Therapeutics to competition

View NeuBase Therapeutics Related Equities

 Risk & Return  Correlation

NeuBase Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how NeuBase Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NeuBase Therapeutics shares will generate the highest return on investment. By undertsting and applying NeuBase Therapeutics stock market strength indicators, traders can identify NeuBase Therapeutics entry and exit signals to maximize returns.

NeuBase Therapeutics Risk Indicators

The analysis of NeuBase Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in NeuBase Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting neubase stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Consideration for investing in NeuBase Stock

If you are still planning to invest in NeuBase Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NeuBase Therapeutics' history and understand the potential risks before investing.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios